Showing results (51-60 of 59) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Diabetes|February 28, 2003
Aldose reductase inhibitor fidarestat prevents retinal oxidative stress and vascular endothelial growth factor overexpression in streptozotocin-diabetic ratsIrina G Obrosova, Alexander G Minchenko, Rukmini Vasupuram, et al.European Journal of Pharmacology|July 24, 2007
A peroxynitrite decomposition catalyst counteracts sensory neuropathy in streptozotocin-diabetic miceViktor R Drel, Pal Pacher, Igor Vareniuk, et al.International Journal of Molecular Medicine|March 13, 2012
Na+/H+-exchanger-1 inhibition counteracts diabetic cataract formation and retinal oxidative-nitrative stress and apoptosisSergey Lupachyk, Roman Stavniichuk, Julia I Komissarenko, et al.Experimental Neurology|May 4, 2007
Nitrosative stress and peripheral diabetic neuropathy in leptin-deficient (ob/ob) miceIgor Vareniuk, Ivan A Pavlov, Viktor R Drel, et al.Biochemical Pharmacology|December 1, 2009
Poly(ADP-ribose) polymerase (PARP) inhibition counteracts multiple manifestations of kidney disease in long-term streptozotocin-diabetic rat modelHanna Shevalye, Roman Stavniichuk, Weizheng Xu, et al.Endocrinology|April 2, 2010
New therapeutic and biomarker discovery for peripheral diabetic neuropathy: PARP inhibitor, nitrotyrosine, and tumor necrosis factor-{alpha}Viktor R Drel, Sergey Lupachyk, Hanna Shevalye, et al.International Journal of Molecular Medicine|November 6, 2007
Evaluation of the peroxynitrite decomposition catalyst Fe(III) tetra-mesitylporphyrin octasulfonate on peripheral neuropathy in a mouse model of type 1 diabetesViktor R Drel, Pal Pacher, Igor Vareniuk, et al.Free Radical Biology & Medicine|November 3, 2007
PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathyIrina G Obrosova, Weizheng Xu, Valeriy V Lyzogubov, et al.Investigative Ophthalmology & Visual Science|December 23, 2008
Poly(ADP-ribose)polymerase inhibition counteracts cataract formation and early retinal changes in streptozotocin-diabetic ratsViktor R Drel, Weizheng Xu, Jie Zhang, et al.Pageof 6